FDAnews
www.fdanews.com/articles/75030-neurocrine-biosciences-reports-second-quarter-2005-results

NEUROCRINE BIOSCIENCES REPORTS SECOND QUARTER 2005 RESULTS

August 4, 2005

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the quarter ended June 30, 2005. For the second quarter, the Company reported a net loss of $5.6 million, or $0.15 per share compared with a net loss of $11.1 million, or $0.31 per share, for the same period last year. For the six months, the Company reported a net loss of $24.4 million, or $0.67 per share, as compared to $23.5 million, or $0.65 per share, for the same period last year.

PharmaLive

(http://www.medadnews.com/News/Index.cfm?articleid=261883)